Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePerioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
- Where
- Beijing, Chengdu, Fuzhou, Guangzhou, Harbin, Jinan, Kunming, Wuwei, Xiamen, Zhengzhou
- Age
- 18 years and over
- People
- 90
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT06155383 - No phaseTaking peopleA Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 58
- Run by
- Fudan University
See details and how to joinNCT06158919 - Phase 2Not yet taking people in ChinaA Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 182
- Run by
- Fudan University
See details and how to joinNCT06152978 - Phase 2Taking peopleXELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study
- Where
- Nanjin
- Age
- 18 years to 75 years
- People
- 43
- Run by
- Xiaofeng Chen
See details and how to joinNCT06091423 - No phaseTaking peopleMRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy
- Where
- Beijing
- Age
- 18 years and over
- People
- 300
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT02988921 - Phase 2Taking peopleCadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 90
- Run by
- Akeso
See details and how to joinNCT05960955 - Phase 1Taking peopleClinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Where
- Wuhu
- Age
- 18 years and over
- People
- 60
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06126406 - Phase 2Taking peopleRadiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 55
- Run by
- Fudan University
See details and how to joinNCT06121700 - Phase 2Taking peopleXELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 80
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05494060 - Phase 2Taking peopleCamrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 75
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT05624099 - Phase 2Taking peopleNeoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Shijiazhuang
- Age
- 18 years to 75 years
- People
- 202
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT03964753 - No phaseTaking peopleAI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
- Where
- Beijing, Changsha, Fuzhou, Guangzhou, Kunming, Nanning, Qingdao, Shanghai, Shenyang, Suzhou, Tianjin, Zhengzhou, Zhenjiang
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Chinese Academy of Sciences
See details and how to joinNCT06035250 - Phase 2Taking peoplePerioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 73
- Run by
- Guo Xufeng
See details and how to joinNCT06056336 - No phaseTaking peopleA Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer
- Where
- Qingdao
- Age
- 18 years to 75 years
- People
- 588
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT06042998 - Phase 1Taking peopleA Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 30
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06043466 - No phaseEnrolling by invitationCarrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 30
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06048926 - No phaseTaking peopleThe Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric
- Where
- Xi'an
- Age
- 18 years to 80 years
- People
- 1,000
- Run by
- Xijing Hospital
See details and how to joinNCT05956847 - No phaseNot yet taking people in ChinaRAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06012214 - Phase 2Taking peopleNeoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
- Where
- Xi'an, Xi’an
- Age
- 18 years to 75 years
- People
- 114
- Run by
- Tang-Du Hospital
See details and how to joinNCT06006650 - Phase 1Taking peopleAdjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma
- Where
- Shantou
- Age
- 18 years to 70 years
- People
- 50
- Run by
- Affiliated Cancer Hospital of Shantou University Medical College
See details and how to joinNCT05984342 - Phase 2Not yet taking people in ChinaPerioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
- Where
- Hangzhou, Huzhou, Lishui, Ningbo, Taizhou
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Yu jiren
See details and how to joinNCT05970627 - Phase 2Taking peoplePerioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
- Where
- Hangzhou, Huzhou, Lishui, Ningbo, Taizhou
- Age
- 18 years to 80 years
- People
- 90
- Run by
- Yu jiren
See details and how to joinNCT05729646 - No phaseTaking peopleMinimally Residual of Esophageal Cancer 001
- Where
- Shijiazhuang
- Age
- 18 years to 75 years
- People
- 56
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT05952661 - No phaseTaking peopleValue of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
- Where
- Hefei, Nantong, Shanghai, Shijiazhuang, Taishing, Taizhou, Tianjin, Xi'an, Xi’an, Zhengzhou
- People
- 385
- Run by
- Fudan University
See details and how to joinNCT05443841 - No phaseNot yet taking people in ChinaLaparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric Cancer
- Where
- Guangzhou
- Age
- 20 years to 80 years
- People
- 216
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05890339